|
2025 Journal Article Peripheral and central elevation of IL-8 in patients with Huntington’s diseaseFung, Jenny N., Lee, John D., Adam, Robert, O’Sullivan, John D. and Woodruff, Trent M. (2025). Peripheral and central elevation of IL-8 in patients with Huntington’s disease. Molecular Immunology, 179, 84-93. doi: 10.1016/j.molimm.2025.02.003 |
|
2025 Other Outputs Dopamine alters motor learning performance in the presence and absence of feedbackLeow, Li-Ann, Tan, Ashley Huey-Ryu, Carroll, Timothy J., Adam, Rob, Dux, Paul E. and Filmer, Hannah L. (2025). Dopamine alters motor learning performance in the presence and absence of feedback. doi: 10.1101/2024.11.23.625034 |
|
2025 Journal Article Clinical utility of 18F-fluorodopa positron emission tomography in the movement disorder clinic: an Australian experienceYeow, Dennis, Fielder, Matthew, Hynard, Shane, Adam, Robert, Katz, Matthew, Lehn, Alexander, Thomas, Paul and O'Sullivan, John D. (2025). Clinical utility of 18F-fluorodopa positron emission tomography in the movement disorder clinic: an Australian experience. Internal Medicine Journal, 55 (2), 207-215. doi: 10.1111/imj.16615 |
|
2025 Journal Article Factors associated with true-positive and false-positive diagnoses of behavioural variant frontotemporal dementia in 100 consecutive referrals from specialist physiciansFlavell, Joshua, Ahern, Emily G. M., Logan, Benignus, Shaw, Thomas B., Adam, Robert J., McElligott, Caitlin A. T. and Nestor, Peter J. (2025). Factors associated with true-positive and false-positive diagnoses of behavioural variant frontotemporal dementia in 100 consecutive referrals from specialist physicians. European Journal of Neurology, 32 (1) e70036, e70036-1. doi: 10.1111/ene.70036 |
|
2024 Journal Article The interplay of age, gender and amyloid on brain and cognition in mid-life and older adultsBorne, Léonie, Thienel, Renate, Lupton, Michelle K., Guo, Christine, Mosley, Philip, Behler, Anna, Giorgio, Joseph, Adam, Robert, Ceslis, Amelia, Bourgeat, Pierrick, Fazlollahi, Amir, Maruff, Paul, Rowe, Christopher C., Masters, Colin L., Fripp, Jurgen, Robinson, Gail A. and Breakspear, Michael (2024). The interplay of age, gender and amyloid on brain and cognition in mid-life and older adults. Scientific Reports, 14 (1) 27207, 1-15. doi: 10.1038/s41598-024-78308-3 |
|
2024 Journal Article The clinical relevance of MOG antibody testing in cerebrospinal fluidReynolds, Molly, Tan, Irene, Nguyen, Kristy, Merheb, Vera, Lee, Fiona X. Z., Trewin, Benjamin P, Lerch, Magdalena, Shah, Snehal, Wolfe, Nigel, Buzzard, Katherine, Lechner-Scott, Jeannette, Fabis-Pedrini, Marzena, Fok, Anthony, John, Nevin, Kneebone, Chris, Yiannikas, Con, Brown, David A., Kermode, Allan G., Reddel, Stephen, Dale, Russell C., Brilot, Fabienne, Ramanathan, Sudarshini, Adam, Robert, Andersen, Jane, Andrews, Ian, Antony, Jayne, Aouad, Patrick, Badve, Monica, Barnett, Michael H. ... on behalf of the Australasian MOGAD Study Group (2024). The clinical relevance of MOG antibody testing in cerebrospinal fluid. Annals of Clinical and Translational Neurology, 11 (9), 1-6. doi: 10.1002/acn3.52163 |
|
2024 Journal Article Long-term efficacy and safety of Rituximab in the treatment of neuromyelitis optica spectrum disorderHayes, Michael Thomas Gerard, Adam, Robert J., McCombe, Pamela Ann, Walsh, Michael and Blum, Stefan (2024). Long-term efficacy and safety of Rituximab in the treatment of neuromyelitis optica spectrum disorder. Multiple Sclerosis Journal, 10 (2) 20552173241257876, 20552173241257876. doi: 10.1177/20552173241257876 |
|
Featured 2024 Journal Article Generation of novel ideas: creativity in Alzheimer’s disease, mild cognitive impairment, and healthy older adultsMarsh, Georgia, Aung, Ohnmar, Ceslis, Amelia, Adam, Robert, Mosley, Philip, Fripp, Jurgen and Robinson, Gail A. (2024). Generation of novel ideas: creativity in Alzheimer’s disease, mild cognitive impairment, and healthy older adults. Creativity Research Journal, 1-16. doi: 10.1080/10400419.2024.2304498 |
|
2023 Journal Article Levetiracetam for the treatment of mild cognitive impairment in Parkinson's disease: a double-blind controlled proof-of-concept trial protocolDissanayaka, Nadeeka, Pourzinal, Dana, Byrne, Gerard J., Yang, Jihyun, McMahon, Katie L., Pontone, Gregory M., O'Sullivan, John D., Adam, Robert, Littleford, Roberta, Chatfield, Mark, Lehn, Alexander, Mari, Zoltan and Bakker, Arnold (2023). Levetiracetam for the treatment of mild cognitive impairment in Parkinson's disease: a double-blind controlled proof-of-concept trial protocol. Pilot and Feasibility Studies, 9 (1) 189, 189. doi: 10.1186/s40814-023-01406-y |
|
2023 Journal Article The Role of Apathy in Spontaneous Verbal and Nonverbal Behaviors: A Transdiagnostic Pilot Study in NeurodegenerationHorne, Kristina S., Ceslis, Amelia, Mosley, Philip, Adam, Robert and Robinson, Gail A. (2023). The Role of Apathy in Spontaneous Verbal and Nonverbal Behaviors: A Transdiagnostic Pilot Study in Neurodegeneration. Cognitive and Behavioral Neurology, 36 (3), 178-193. doi: 10.1097/wnn.0000000000000345 |
|
2023 Journal Article Advanced Parkinson’s disease: a clinical challengeAdam, Robert J. (2023). Advanced Parkinson’s disease: a clinical challenge. Medicine Today, 24 (1-2), 12-21. |
|
2022 Conference Publication Update on TRIP: Therapy to reduce dementia risk in Parkinson’s disease proof of concept trialPourzinal, D., Bakker, A., Byrne, G.J., McMahon, K., O’Sullivan, J.D., Adam, R., Lehn, A., Copland, D., Yang, J.H., Au, T., Littleford, R., Chatfield, M., Pontone, G., Mari, Z. and Dissanayaka, N. (2022). Update on TRIP: Therapy to reduce dementia risk in Parkinson’s disease proof of concept trial. UQ Centre for Clinical Research HDR Symposium, Brisbane, QLD Australia, 24 November 2022. |
|
2022 Conference Publication LC-MS based urine metabolomic profiling indicate altered gut microbiome and host lipid metabolites in Parkinson's diseaseJewell, Shannon, Roper, Kerry, Woodhouse, Helen, Adam, Robert, O'Sullivan, John and Gordon, Richard (2022). LC-MS based urine metabolomic profiling indicate altered gut microbiome and host lipid metabolites in Parkinson's disease. Experimental Biology 2022 Meeting, Philadelphia, PA United States, 2-5 April 2022. Hoboken, NJ United States: John Wiley and Sons. doi: 10.1096/fasebj.2022.36.S1.R2928 |
|
2022 Conference Publication A Novel Role for Glucocerebrosidase 1 (GBA1) in Parkinson's DiseaseJayabalan, Nanthini, Roper, Katherine Kerry, Woodhouse, Helen M., Adam, Robert J., O'Sullivan, John D. and Gordon, Richard (2022). A Novel Role for Glucocerebrosidase 1 (GBA1) in Parkinson's Disease. Experimental Biology Meeting 2022, Philadelphia, PA United States, 2-5 April 2022. Hoboken, NJ United States: John Wiley and Sons. doi: 10.1096/fasebj.2022.36.S1.R5391 |
|
2022 Journal Article A snapshot of brain and cognition in healthy mid-life and older adultsBorne, Léonie, Lupton, Michelle K., Guo, Christine, Mosley, Philip, Adam, Robert, Ceslis, Amelia, Bourgeat, Pierrick, Fazlollahi, Amir , Maruff, Paul, Rowe, Christopher C., Masters, Colin L., Fripp, Jurgen , Robinson, Gail A. and Breakspear, Michael (2022). A snapshot of brain and cognition in healthy mid-life and older adults. bioRxiv. doi: 10.1101/2022.01.20.476706 |
|
2022 Conference Publication Update on TRIP: Therapy to reduce dementia risk in Parkinson’s disease proof of concept trialPourzinal, D., Bakker, A., Byrne, G.J., McMahon, K., O’Sullivan, J.D., Adam, R., Lehn, A., Copland, D., Yang, J.H., Au, T., Littleford, R., Chatfield, M., Pontone, G., Mari, Z. and Dissanayaka, N. (2022). Update on TRIP: Therapy to reduce dementia risk in Parkinson’s disease proof of concept trial. UQ Neurosciences Symposium, Brisbane, QLD Australia, 26-27 September 2022. |
|
2021 Journal Article Biallelic AOPEP loss-of-function variants cause progressive dystonia with prominent limb involvementZech, Michael, Kumar, Kishore R., Reining, Sophie, Reunert, Janine, Tchan, Michel, Riley, Lisa G., Drew, Alexander P., Adam, Robert J., Berutti, Riccardo, Biskup, Saskia, Derive, Nicolas, Bakhtiari, Somayeh, Sheng, Chih Jin, Kruer, Michael C., Bardakjian, Tanya, Gonzalez-Alegre, Pedro, Sarmiento, Ignacio J. Keller, Mencacci, Niccolo E., Lubbe, Steven J., Kurian, Manju A., Clot, Fabienne, Méneret, Aurélie, de Sainte Agathe, Jean-Madeleine, Fung, Victor S.C., Vidailhet, Marie, Baumann, Matthias, Marquardt, Thorsten, Winkelmann, Juliane and Boesch, Sylvia (2021). Biallelic AOPEP loss-of-function variants cause progressive dystonia with prominent limb involvement. Movement Disorders, 37 (1), 137-147. doi: 10.1002/mds.28804 |
|
2021 Conference Publication Therapy to reduce dementia risk in Parkinson’s disease (TRIP): Proof-of-concept protocolPourzinal, D., Bakker, A., Byrne, G.J., McMahon, K., O’Sullivan, J., Adam, R., Copland, D., Yang, J.H.J., Au, T., Littleford, R., Chatfield, M., Pontone, G., Mari, Z. and Dissanayaka, N. (2021). Therapy to reduce dementia risk in Parkinson’s disease (TRIP): Proof-of-concept protocol. Australia Dementia Forum 2021, Online, 31 May - 1 June 2021. |
|
2021 Journal Article An Australian state-based cohort study of autoimmune encephalitis cases detailing clinical presentation, investigation results, and response to therapySwayne, Andrew, Warren, Nicola, Prain, Kerri, Gillis, David, O'Gorman, Cullen, Tsang, Benjamin K-T., Muller, Claire, Broadley, Simon, Adam, Robert J., McCombe, Pamela, Wong, Richard C. and Blum, Stefan (2021). An Australian state-based cohort study of autoimmune encephalitis cases detailing clinical presentation, investigation results, and response to therapy. Frontiers in Neurology, 12 607773, 607773. doi: 10.3389/fneur.2021.607773 |
|
2020 Conference Publication Therapy to reduce dementia risk in Parkinson’s disease (TRIP): proof-of-concept protocolPourzinal, D., Bakker, A., Byrne, G. J., McMahon, K., O'Sullivan, J., Adam, R., Copland, D., Yang, J. H. J., Au, T., Littleford, R., Chatfield, M., Pontone, G., Mari, G. and Dissanayaka, N. (2020). Therapy to reduce dementia risk in Parkinson’s disease (TRIP): proof-of-concept protocol. Herston Health Precinct Symposium 2020, Brisbane, QLD Australia, 7-11 December 2020. |
